State Policy Influence on Buprenorphine Adoption in Treatment Programs
Author Information
Author(s): Lori J Ducharme, Amanda J Abraham
Primary Institution: University of Georgia
Hypothesis
The study examines the impact of state policies on the adoption of buprenorphine in community treatment programs.
Conclusion
State Medicaid coverage for buprenorphine significantly influences its adoption in treatment programs.
Supporting Evidence
- Programs with Medicaid coverage for buprenorphine were 8.5% more likely to adopt it.
- Government-funded programs were less likely to adopt buprenorphine compared to for-profit programs.
- Programs offering detox services were over 7 times more likely to adopt buprenorphine.
Takeaway
This study found that if states include buprenorphine in their Medicaid plans, more treatment programs will use it to help people with opioid addiction.
Methodology
Interviews with state agency staff and analysis of data from the 2006 National Survey of Substance Abuse Treatment Services.
Potential Biases
Potential bias due to reliance on self-reported data from treatment facilities.
Limitations
The study only considered the perspectives of state agencies and did not include other relevant agencies like Medicaid offices.
Participant Demographics
The study included treatment programs across the U.S., with a focus on those providing substance abuse treatment.
Statistical Information
P-Value
0.081
Confidence Interval
(0.011, 0.152)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website